In the validation cohort, median GP73 and LG2m levels were also higher overall in patients with fibrosis/cirrhosis (GP73 105.14 ng/mL; LG2m 31.70 pg/mL) compared to healthy controls (GP73 51.80 ng/mL; LG2m 10.40 pg/mL; Fig. 1C, D). This evidence concerns the gene GOLM1 and fibrosis.